The Examples for the Influence of GMP Compliance to the Availability of Reference Listed Drug for Generic Drug Product in China

Yang Dongsheng, Niu Jianzhao, Feng Yufei, Qi Mengjie, Zhai Chenfei, Ma Lingyun

Chinese Pharmaceutical Affairs ›› 2025, Vol. 39 ›› Issue (2) : 132-138.

PDF(4799 KB)
PDF(4799 KB)
Chinese Pharmaceutical Affairs ›› 2025, Vol. 39 ›› Issue (2) : 132-138. DOI: 10.16153/j.1002-7777.2024-08-0047
Supervision & Administration

The Examples for the Influence of GMP Compliance to the Availability of Reference Listed Drug for Generic Drug Product in China

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2025, 39(2): 132-138 https://doi.org/10.16153/j.1002-7777.2024-08-0047

References

List( Publishing order | Descend order by publishing year | Descend order by cited within ) Chart analysis

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(4799 KB)

Accesses

Citation

Detail
Sections
Recommended
京ICP备17052540号-4
Copyright © Chinese Pharmaceutical Affairs, All Rights Reserved.
Powered by Beijing Magtech Co. Ltd.

/

〈 〉